Verfolgen Sie die neuesten Nachrichten aus den Bereichen Consumer Healthcare, Pharma Rx, Kosmetik, Nahrungsergänzungsmittel, FMCG, Großhandel, Einzelhandel und Produktion! (Auf Englisch)
CPC ist ein Expertenteam mit langjähriger Erfahrung in den Bereichen Strategie & Marketing, Aufbau eines internationalen Geschäfts, Lizenzierung, M&A, Regulierung, Registrierung, Veröffentlichungen, Suche nach Führungskräften und mehr! (Auf Englisch)
CPC Publication Services bietet genaue analytische Daten, die es uns ermöglichen, unseren Kunden wichtige aktuelle Informationen und tiefe Einblicke in die Trends der Pharma- und OTC-Branche zu geben. (Auf Englisch)
Wir von Chameleon Pharma Consulting sind die Experten mit mehr als 20 Jahren Erfahrung in Bereichen wie Consumer Healthcare, Pharma Rx, Kosmetik, Nahrungsergänzungsmittel, FMCG, Großhandel, Einzelhandel, Produktion. (Auf Englisch)
Vietnam’s Aesthetic Medicine Market: Technology, Personalization, and Growth till 2035
Vietnam’s aesthetic medicine market exceeds USD 355M and is growing at 8.6% CAGR through 2035, driven by a rapidly expanding middle class who represents the core customer base for aesthetic medicine procedures....
Global Women’s Health Trends: Natural Solutions for Menopause & UTI Prevention, A Growing Opportunity Beyond Antibiotics
Women’s health is one of the fastest-growing segments in the global OTC and consumer healthcare market, especially in menopause management and UTI prevention. The sector is expected to grow at around 7% CAGR globally over the next decade....
Canada’s Consumer Health Shift: What Pharmacy Chains and New Behaviors Mean for Pharma Market in 2040?
Canada’s OTC & Pharma market, valued at approx. USD 28B in 2025, is projected to reach nearly USD 61B by 2030 at a CAGR of about 6.2%, driven by expanding pharmacy chains and changing consumer health trends....
Thailand Medical Device Boom: Regulatory Strategy & Growth Opportunities to 2040
The Thailand medical device market is projected to expand from approximately USD 4.03 billion by 2030 to nearly USD 8.5 billion by 2040, reflecting an estimated CAGR of around 7.70%....
Colombian Women’s Health OTC & Pharma Market by 2035: Opportunities in Contraceptives, Menopause, and Intimate Care
As one of the leading pharma markets in Latin America, Colombia presents a dynamic landscape for the Women’s Health segment. With a female population of 18.3 million between the ages of 15 and 64, the market is being reshaped by a clear shift toward premium and natural products. ...
Why Italy’s Aesthetic Medicine Market is Set to Double by 2040
Italian aesthetic medicine is seeing strong momentum as Gen Z and Gen Alpha move from “repair” to prejuvenation, with an expected CAGR of 15,4% by 2040. Hyaluronic acid (HA) dermal fillers are the most common non-surgical procedures, whereas breast augmentation represents the most performed surgical procedure....
EAEU GMP Pre-Audit: How to Ensure a 99% Success Rate During Inspection?
In the rapidly evolving pharma & OTC landscape of the Eurasian Economic Union (EAEU), obtaining a Good Manufacturing Practice (GMP) certificate is no longer just a regulatory hurdle: it is a strategic gateway to a market of over 180 million people. Learn how CPC Pre-Audits & CAPA support ensure successful inspections....
EU-India Free Trade Agreement: Tariffs Down of Up To 100%. What awaits European Pharma SMEs?
India and the EU officially announced an historic Free Trade Agreement (FTA) in New Delhi. This landmark deal is set to eliminate tariffs on over 95% of trade lines, reducing duties of up to 100%, and open a rapidly growing market of 1.4 billion people. What awaits European Pharma SMEs?...
